{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:35:53Z","timestamp":1789140953863,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                <jats:title>Abstract<\/jats:title>\n                <jats:p>Transporter associated with antigen processing 1 (TAP1) is a transporter protein that represent tumor antigen in the MHC I or HLA complex. Any defect in the\u00a0TAP1 gene resulting in inadequate tumor tracking. TAP1 influences multidrug resistance (MDR) in human cancer cell lines and hinders the treatment during chemotherapeutic. The association of TAP1 in cancer progression remains mostly unknown and further study of the gene in relation with cancer need to conduct. Thus, the study has designed to analyze the association between the TAP1 with cancer by computationally. The expression pattern of the gene has determined by using ONCOMINE, GENT2, and GEPIA2 online platforms. The protein level of TAP1 was examined by the help of Human Protein Atlas. Samples with different clinical outcomes were investigated to evaluate the expression and promoter methylation in cancer vs. normal tissues by using UALCAN server. The copy number alteration, mutation frequency, and expression level of the gene in different cancer were analyzed by using cBioPortal server. The PrognoScan and KM plotter platforms were used to perform the survival analysis and represented graphically. Additionally, pathway and gene ontology (GO) features correlated to the TAP1 gene were analyzed and presented by bar charts. After arranging the data in a single panel like correlating expression to prognosis, mutational and alterations characteristic, and pathways analysis, we observed some interesting insights that emphasized the importance of the gene in cancer progression. The study found the relationship between the TAP1 expression pattern and prognosis in different cancer tissues and shows how TAP1 affects the clinical characteristics. The analytical data presented in the study is vital to learn about the effect of TAP1 in tumor tissue, where previously studies showing contradicting expression of TAP1 in cancer tissue. The analyzed data can also be utilized further to evade the threats against chemotherapy. Overall, the study provided a new aspect to consider the role of TAP1 gene in cancer progression and survival status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key messages<\/jats:title>\n                <jats:p>\u2022 This study demonstrated, for the first time, a correlation between the TAP1 gene and tumor progression.<\/jats:p>\n                <jats:p>\u2022 An upregulation of TAP1 mRNA was demonstrated in various cancer types.<\/jats:p>\n                <jats:p>\u2022 This study reported a significant negative correlation for TAP1 gene expression and the survival rate in different cancer types.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00109-021-02088-w","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T08:05:51Z","timestamp":1622189151000},"page":"1293-1309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Transporter associated with antigen processing 1 (TAP1) expression and prognostic analysis in breast, lung, liver, and ovarian cancer"],"prefix":"10.1007","volume":"99","author":[{"given":"Anika","family":"Tabassum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Nazmus","family":"Samdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarak Chandra","family":"Dhali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahat","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foysal","family":"Ahammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdus","family":"Samad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6599-9204","authenticated-orcid":false,"given":"Tomasz M.","family":"Karpi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"issue":"6","key":"2088_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2088_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7\u201334","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2088_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","volume":"53","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM (2002) Mechanisms of cancer drug resistance. Annu Rev Med 53(1):615\u2013627","journal-title":"Annu Rev Med"},{"issue":"7","key":"2088_CR4","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0022-2275(20)31588-1","volume":"42","author":"M Dean","year":"2001","unstructured":"Dean M, Hamon Y, Chimini G (2001) The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 42(7):1007\u20131017","journal-title":"J Lipid Res"},{"issue":"2","key":"2088_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0005-2736(99)00171-6","volume":"1461","author":"R Abele","year":"1999","unstructured":"Abele R, Tamp\u00eb R (1999) Function of the transport complex TAP in cellular immune recognition. Biochim Biophys Acta (BBA)-Biomembr 1461(2):405\u2013419","journal-title":"Biochim Biophys Acta (BBA)-Biomembr"},{"issue":"3","key":"2088_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0014-5793(99)01676-2","volume":"464","author":"B Lankat-Buttgereit","year":"1999","unstructured":"Lankat-Buttgereit B, Tamp\u00e9 R (1999) The transporter associated with antigen processing TAP: structure and function. FEBS Lett 464(3):108\u2013112","journal-title":"FEBS Lett"},{"issue":"4","key":"2088_CR7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1152\/physiol.00002.2004","volume":"19","author":"R Abele","year":"2004","unstructured":"Abele R, Tamp\u00e9 R (2004) The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing. Physiology 19(4):216\u2013224","journal-title":"Physiology"},{"issue":"7","key":"2088_CR8","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0092-8674(05)80068-6","volume":"71","author":"L Van Kaer","year":"1992","unstructured":"Van Kaer L, Ashton-Rickardt PG, Ploegh HL, Tonegawa S (1992) TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell 71(7):1205\u20131214","journal-title":"Cell"},{"issue":"17","key":"2088_CR9","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.1158\/0008-5472.CAN-04-3977","volume":"65","author":"Y Lou","year":"2005","unstructured":"Lou Y et al (2005) Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival. Cancer Res 65(17):7926","journal-title":"Cancer Res"},{"issue":"1","key":"2088_CR10","first-page":"1","volume":"9","author":"MF Ullah","year":"2008","unstructured":"Ullah MF (2008) Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy. Asian Pac J Cancer Prev 9(1):1\u20136","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"2088_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/1479-7364-3-3-281","volume":"3","author":"V Vasiliou","year":"2009","unstructured":"Vasiliou V, Vasiliou K, Nebert DW (2009) Human ATP-binding cassette (ABC) transporter family. Human genomics 3(3):281","journal-title":"Human genomics"},{"issue":"6","key":"2088_CR12","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1021\/mp200261n","volume":"8","author":"C-P Wu","year":"2011","unstructured":"Wu C-P, Hsieh C-H, Wu Y-S (2011) The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy. Mol Pharm 8(6):1996\u20132011","journal-title":"Mol Pharm"},{"issue":"6","key":"2088_CR13","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","volume":"74","author":"SW Lowe","year":"1993","unstructured":"Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74(6):957\u2013967","journal-title":"Cell"},{"issue":"1","key":"2088_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","volume":"39","author":"SV Ambudkar","year":"1999","unstructured":"Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39(1):361\u2013398","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"19","key":"2088_CR15","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1093\/jnci\/91.19.1604","volume":"91","author":"WS Dalton","year":"1999","unstructured":"Dalton WS, Scheper RJ (1999) Lung resistance-related protein: determining its role in multidrug resistance. J Natl Cancer Inst 91(19):1604\u20131605","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"2088_CR16","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/bjc.1996.660","volume":"74","author":"MA Izquierdo","year":"1996","unstructured":"Izquierdo MA, Neefjes JJ, Mathari AEL, Flens MJ, Scheffer GL, Scheper RJ (1996) Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines. Br J Cancer 74(12):1961\u20131967","journal-title":"Br J Cancer"},{"issue":"2","key":"2088_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.bbcan.2007.05.002","volume":"1775","author":"J-P Gillet","year":"2007","unstructured":"Gillet J-P, Efferth T, Remacle J (2007) Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochim Biophys Acta (BBA)-Rev Cancer 1775(2):237\u2013262","journal-title":"Biochim Biophys Acta (BBA)-Rev Cancer"},{"issue":"2-3","key":"2088_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0014-5793(01)02722-3","volume":"503","author":"H Lage","year":"2001","unstructured":"Lage H et al (2001) Enhanced expression of human ABC-transporter tap is associated with cellular resistance to mitoxantrone. FEBS Lett 503(2-3):179\u2013184","journal-title":"FEBS Lett"},{"issue":"1","key":"2088_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes DR et al (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6(1):1\u20136","journal-title":"Neoplasia"},{"issue":"6","key":"2088_CR20","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.1016\/j.ygeno.2020.09.002","volume":"112","author":"A Samad","year":"2020","unstructured":"Samad A, Jafar T, Rafi JH (2020) Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses. Genomics 112(6):4912\u20134923","journal-title":"Genomics"},{"key":"2088_CR21","doi-asserted-by":"crossref","unstructured":"Samad A et al (2020) Computational assessment of MCM2 transcriptional expression and identification of the prognostic biomarker for human breast cancer. Heliyon 6(10)","DOI":"10.1016\/j.heliyon.2020.e05087"},{"issue":"W1","key":"2088_CR22","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45(W1):W98\u2013W102","journal-title":"Nucleic Acids Res"},{"key":"2088_CR23","doi-asserted-by":"publisher","first-page":"CIN. S7226","DOI":"10.4137\/CIN.S7226","volume":"10","author":"G Shin","year":"2011","unstructured":"Shin G, Kang T-W, Yang S, Baek S-J, Jeong Y-S, Kim S-Y (2011) GENT: gene expression database of normal and tumor tissues. Cancer Informat 10:CIN. S7226","journal-title":"Cancer Informat"},{"issue":"8","key":"2088_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS et al (2017) UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19(8):649\u2013658","journal-title":"Neoplasia"},{"key":"2088_CR25","doi-asserted-by":"crossref","unstructured":"Uhl\u00e9n M et al (2015) Tissue-based map of the human proteome. Science 347(6220):1260419","DOI":"10.1126\/science.1260419"},{"issue":"1, Part 2","key":"2088_CR26","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.ygeno.2020.11.012","volume":"113","author":"JH Rafi","year":"2021","unstructured":"Rafi JH et al (2021) High expression of bone morphogenetic protein 1 (BMP1) is associated with a poor survival rate in human gastric cancer, a dataset approaches. Genomics 113(1, Part 2):1141\u20131154","journal-title":"Genomics"},{"key":"2088_CR27","doi-asserted-by":"crossref","unstructured":"E. Cerami et al. 2012 \u201cThe cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data,\u201d ed: AACR.","DOI":"10.1158\/2159-8290.CD-12-0095"},{"issue":"269","key":"2088_CR28","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6(269):pl1","journal-title":"Sci Signal"},{"issue":"1","key":"2088_CR29","first-page":"18","volume":"2","author":"H Mizuno","year":"2009","unstructured":"Mizuno H, Kitada K, Nakai K, Sarai A (2009) PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genet 2(1):18","journal-title":"BMC Med Genet"},{"issue":"W1","key":"2088_CR30","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV et al (2016) Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44(W1):W90\u2013W97","journal-title":"Nucleic Acids Res"},{"key":"2088_CR31","doi-asserted-by":"crossref","unstructured":"Leclerc M et al (2019) Recent advances in lung cancer immunotherapy: input of T-cell epitopes associated with impaired peptide processing. Front Immunol 10(1505)","DOI":"10.3389\/fimmu.2019.01505"},{"issue":"5","key":"2088_CR32","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1172\/JCI6455","volume":"103","author":"M Raghavan","year":"1999","unstructured":"Raghavan M (1999) Immunodeficiency due to defective antigen processing: the molecular basis for type 1 bare lymphocyte syndrome. J Clin Invest 103(5):595\u2013596","journal-title":"J Clin Invest"},{"key":"2088_CR33","doi-asserted-by":"crossref","unstructured":"Keusekotten K, Leonhardt RM, Ehses S, Knittler MR Biogenesis of functional antigenic peptide transporter TAP requires assembly of pre-existing TAP1 with newly synthesized TAP2. J Biol Chem 281(26):17545\u201317551","DOI":"10.1074\/jbc.M602360200"},{"key":"2088_CR34","doi-asserted-by":"crossref","unstructured":"Mou MA et al (2020) Validation of CSN1S1 transcriptional expression, promoter methylation, and prognostic power in breast cancer using independent datasets. Biochem Biophys Rep 24:100867","DOI":"10.1016\/j.bbrep.2020.100867"},{"key":"2088_CR35","doi-asserted-by":"crossref","unstructured":"Rahman F et al (2020) A multi-omics approach to reveal the key evidence of GDF10 as a novel therapeutic biomarker for breast cancer. Inform Med Unlocked 21:100463","DOI":"10.1016\/j.imu.2020.100463"},{"key":"2088_CR36","doi-asserted-by":"crossref","unstructured":"Karim MA et al (2020) A multi-omics analysis of bone morphogenetic protein 5 (BMP5) mRNA expression and clinical prognostic outcomes in different cancers using bioinformatics approaches. Biomedicines 8(2)","DOI":"10.3390\/biomedicines8020019"},{"key":"2088_CR37","doi-asserted-by":"crossref","unstructured":"Barman UD et al (2020) Clinicopathological and prognostic significance of GPC3 in human breast cancer and its 3D structure prediction. Network Model Analys Health Inform Bioinform 9(1):24","DOI":"10.1007\/s13721-020-00234-x"},{"key":"2088_CR38","doi-asserted-by":"crossref","unstructured":"Saha SK et al (2020) Prognostic and clinico-pathological significance of BIN1 in breast cancer. Inform Med Unlocked 19:100327","DOI":"10.1016\/j.imu.2020.100327"},{"issue":"7","key":"2088_CR39","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1101\/gr.184901","volume":"11","author":"M Dean","year":"2001","unstructured":"Dean M, Rzhetsky A, Allikmets R (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11(7):1156\u20131166","journal-title":"Genome Res"},{"key":"2088_CR40","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3389\/fimmu.2019.01505","volume":"10","author":"M Leclerc","year":"2019","unstructured":"Leclerc M, Guillebot De Nerville G, Tihy I, Malenica I, Mezquita L, Mami-Chouaib F (2019) Recent advances in lung cancer immunotherapy: input of T-cell epitopes associated with impaired peptide processing. Front Immunol 10:1505","journal-title":"Front Immunol"},{"issue":"1","key":"2088_CR41","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1038\/s41467-019-11728-2","volume":"10","author":"G Garrido","year":"2019","unstructured":"Garrido G et al (2019) Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity. Nat Commun 10(1):3773","journal-title":"Nat Commun"},{"issue":"3","key":"2088_CR42","first-page":"205","volume":"45","author":"M Kaczmarek","year":"2007","unstructured":"Kaczmarek M et al (2007) Analysis of expression of MHC class I molecules and TAP genes in malignant human cell lines. Folia Histochem Cytobiol 45(3):205\u2013214","journal-title":"Folia Histochem Cytobiol"},{"issue":"8","key":"2088_CR43","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.4049\/jimmunol.163.8.4224","volume":"163","author":"AK Johnsen","year":"1999","unstructured":"Johnsen AK, Templeton DJ, Sy MS, Harding CV (1999) Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis. J Immunol 163(8):4224","journal-title":"J Immunol"},{"issue":"11","key":"2088_CR44","doi-asserted-by":"publisher","first-page":"e1356143","DOI":"10.1080\/2162402X.2017.1356143","volume":"6","author":"A Ling","year":"2017","unstructured":"Ling A et al (2017) TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer. Oncoimmunol 6(11):e1356143","journal-title":"Oncoimmunol"},{"issue":"2","key":"2088_CR45","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/ng0696-210","volume":"13","author":"HL Chen","year":"1996","unstructured":"Chen HL, Gabrilovich D, Tamp\u00e9 R, Girgis KR, Nadaf S, Carbone DP (1996) A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer. Nat Genet 13(2):210\u2013213","journal-title":"Nat Genet"},{"issue":"1","key":"2088_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1084\/jem.179.1.335","volume":"179","author":"FV Cromme","year":"1994","unstructured":"Cromme FV et al (1994) Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J Exp Med 179(1):335\u2013340","journal-title":"J Exp Med"},{"issue":"15","key":"2088_CR47","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1128\/JVI.77.15.8299-8309.2003","volume":"77","author":"K Herzer","year":"2003","unstructured":"Herzer K et al (2003) Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity. J Virol 77(15):8299\u20138309","journal-title":"J Virol"},{"issue":"11","key":"2088_CR48","doi-asserted-by":"publisher","first-page":"e0187323","DOI":"10.1371\/journal.pone.0187323","volume":"12","author":"AM Henle","year":"2017","unstructured":"Henle AM, Nassar A, Puglisi-Knutson D, Youssef B, Knutson KL (2017) Downregulation of TAP1 and TAP2 in early stage breast cancer. PLoS One 12(11):e0187323","journal-title":"PLoS One"},{"issue":"5B","key":"2088_CR49","doi-asserted-by":"publisher","first-page":"s74","DOI":"10.1053\/jhep.2002.36807","volume":"36","author":"HB El-Serag","year":"2002","unstructured":"El-Serag HB (2002) Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36(5B):s74\u2013s83","journal-title":"Hepatology"},{"key":"2088_CR50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pharmthera.2018.06.013","volume":"192","author":"LC Czuba","year":"2018","unstructured":"Czuba LC, Hillgren KM, Swaan PW (2018) Post-translational modifications of transporters. Pharmacol Ther 192:88\u201399","journal-title":"Pharmacol Ther"},{"issue":"4","key":"2088_CR51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2174\/138920111795164075","volume":"12","author":"EI Stolarczyk","year":"2011","unstructured":"Stolarczyk EI, Reiling CJ, Paumi CM (2011) Regulation of ABC transporter function via phosphorylation by protein kinases. Curr Pharm Biotechnol 12(4):621\u2013635","journal-title":"Curr Pharm Biotechnol"},{"issue":"3","key":"2088_CR52","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jtcvs.2010.04.031","volume":"141","author":"S Qifeng","year":"2011","unstructured":"Qifeng S, Bo C, Xingtao J, Chuanliang P, Xiaogang Z (2011) Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics. J Thorac Cardiovasc Surg 141(3):808\u2013814","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"2088_CR53","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1186\/s12864-015-1994-2","volume":"16","author":"M Moarii","year":"2015","unstructured":"Moarii M, Boeva V, Vert J-P, Reyal F (2015) Changes in correlation between promoter methylation and gene expression in cancer. BMC Genomics 16(1):873","journal-title":"BMC Genomics"},{"issue":"1","key":"2088_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1476-4598-3-9","volume":"3","author":"C Garnis","year":"2004","unstructured":"Garnis C, Buys TPH, Lam WL (2004) Genetic alteration and gene expression modulation during cancer progression. Mol Cancer 3(1):9","journal-title":"Mol Cancer"},{"issue":"12","key":"2088_CR55","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1158\/1078-0432.CCR-16-1946","volume":"23","author":"C Pereira","year":"2017","unstructured":"Pereira C et al (2017) Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairing immunorecognition. Clin Cancer Res 23(12):3203\u20133213","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2088_CR56","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1172\/JCI5687","volume":"103","author":"H de la Salle","year":"1999","unstructured":"de la Salle H et al (1999) HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J Clin Invest 103(5):R9\u2013R13","journal-title":"J Clin Invest"},{"issue":"13","key":"2088_CR57","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1158\/0008-5472.CAN-07-6595","volume":"68","author":"T Bonome","year":"2008","unstructured":"Bonome T et al (2008) A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. Cancer Res 68(13):5478\u20135486","journal-title":"Cancer Res"},{"issue":"9","key":"2088_CR58","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.annonc.2020.05.019","volume":"31","author":"J Millstein","year":"2020","unstructured":"Millstein J et al (2020) Prognostic gene expression signature for high-grade serous ovarian cancer. Ann Oncol 31(9):1240\u20131250","journal-title":"Ann Oncol"},{"issue":"4","key":"2088_CR59","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4110\/in.2017.17.4.214","volume":"17","author":"M Lee","year":"2017","unstructured":"Lee M, Rhee I (2017) Cytokine signaling in tumor progression. Immune network 17(4):214\u2013227","journal-title":"Immune network"},{"issue":"6","key":"2088_CR60","doi-asserted-by":"publisher","first-page":"7204","DOI":"10.18632\/oncotarget.23208","volume":"9","author":"L Chen","year":"2017","unstructured":"Chen L et al (2017) Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9(6):7204\u20137218","journal-title":"Oncotarget"},{"issue":"24","key":"2088_CR61","doi-asserted-by":"publisher","first-page":"7168","DOI":"10.1158\/0008-5472.CAN-14-2458","volume":"74","author":"CY Slaney","year":"2014","unstructured":"Slaney CY, Kershaw MH, Darcy PK (2014) Trafficking of T cells into tumors. Cancer Res 74(24):7168","journal-title":"Cancer Res"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-021-02088-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-021-02088-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-021-02088-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T19:03:09Z","timestamp":1675364589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-021-02088-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2088"],"URL":"https:\/\/doi.org\/10.1007\/s00109-021-02088-w","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,28]]},"assertion":[{"value":"1 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}